About Genomines
Genomines is a Natural Resources company based in Paris (France) founded in 2021 by Dali Rashid. Enhanced plants are utilized for renewable nickel and metal extraction. Genomines has raised $50.2 million across 2 funding rounds from investors including Lowercarbon Capital, Nicolas Douay and Sake Bosch. Genomines offers products and services including Phytomining Technology and Biomass Processing. Its focus areas include Enterprise Applications, Mining Tech, Operations and Mineral Extraction.
Company details
Genomines was founded in 2021 in Paris, France, operating in the synthetic biology sector focused on environmental remediation and metal recovery. Plants natural biology is enhanced to extract nickel and other metals from metal-rich fields and mine tailings. Growth is optimized through microbiome improvements, reducing reliance on synthetic fertilizers. Metals are recovered from harvested biomass using bioleaching and combined techniques, with processes designed for carbon neutrality in downstream operations.
- Headquarters Paris, France
- Founders Dali Rashid
- SectorsNatural Resources
- Website genomines.com
- Social LinkedIn
- Total Equity Funding$50.2M (USD)
in 2 rounds
- Latest Funding Round$45M (USD), Series A
Sep 2025
- InvestorsLowercarbon Capital
& 14 more
Products & Services of Genomines
Genomines offers a comprehensive portfolio of products and services, including Phytomining Technology and Biomass Processing.
Enhances plants to extract metals like nickel from soil efficiently
Recovers metals from harvested plants using eco-friendly techniques
Funding Insights of Genomines
Genomines has successfully raised a total of $50.2M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $45 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $50.2M
- Total Rounds 2
- Last Round Series A — $45M
- First Round $5.2M
(Oct 2021)
- Investors Count 15
All 2 funding rounds of Genomines with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $45M | Series A | – | Engine Ventures, Forbion | |
| Oct 2021 | $5.2M | Seed | – | Lowercarbon Capital |
15 investors in total: 12 institutional and 3 angel.
Investors in Genomines
Genomines has secured backing from 15 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Lowercarbon Capital, Nicolas Douay and Sake Bosch.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on tech startups | lowercarboncapital.com | New York, United States | ||
Early-stage technology startups are funded by Engine Ventures venture capital. | engineventures.com | Cambridge, United States | ||
Venture capital firm focused on lifescience and healthcare sectors | forbion.com | Naarden, Netherlands | ||
Investment in Deep-Tech and Climate-Tech companies is facilitated. | dtcf.de | Bonn, Germany | ||
Early-stage tech investments are targeted in Europe, US, and Asia. | wind.capital | Paris, France | ||
Prospect Innovation is focused on accelerating sustainable innovation in the metals and mining industry. | prospectinnovation.com | |||
RAISE Sherpas is recognized as a philanthropic accelerator for startups and associations. | 2015 | raise-sherpas.co | ||
Provider of a program turning individuals into funded technology company founders | joinef.com | London, United Kingdom | ||
Develops innovative automotive technologies and proprietary solutions for various sectors. | 2000 | hyundaimotorgroup.com | Seoul, South Korea | |
Invests in startups addressing climate, health, and tech challenges. | 2020 | teampact.ventures | Paris, France |
Investor details for Genomines
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genomines
2 people are tracked at Genomines (2 in leadership).
| Name | Role | Group |
|---|---|---|
Dali Rashid | Co-Founder | Leadership |
Fabien Koutchekian | CEO | Leadership |
Complete people profiles for Genomines
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genomines
3 dated milestones of Genomines across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Genomines is founded.
- Funding First funding round of $5.2M.
- Funding Latest funding round, Series A, of $45.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genomines
Genomines was founded in 2021.
Genomines is headquartered in Paris, France.
Genomines is a funded company, having raised a total of $50.2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $5.2M, raised on Oct 2021.
Genomines was founded in 2021 in Paris, France, operating in the synthetic biology sector focused on environmental remediation and metal recovery. Plants natural biology is enhanced to extract nickel and other metals from metal-rich fields and mine tailings. Growth is optimized through microbiome improvements, reducing reliance on synthetic fertilizers. Metals are recovered from harvested biomass using bioleaching and combined techniques, with processes designed for carbon neutrality in downstream operations.
Genomines offers Phytomining Technology and Biomass Processing.
Genomines has 15 investors. Key investors include Lowercarbon Capital, Nicolas Douay, Sake Bosch, David Helgason, and Engine Ventures.